These novel medications , Retatrutide, represent a remarkable advancement in managing type 2 diabetes and conceivably associated disorders. They all are grouped as GLP-1 hormone agonists , indicating they function to replicate the body's GLP-1 peptide, stimulating insulin secretion and reducing food intake. Despite Semaglutide each operates larg… Read More